Dr. Elisa R Port

Dr. Elisa R. Port, MD, is a nationally acclaimed breast surgical oncologist and serves as Chief of Breast Surgery and Co-Director of the Dubin Breast Center at the Tisch Cancer Institute at Mount Sinai. She received her medical degree from Mount Sinai School of Medicine, completed her general surgery residency at Cedars-Sinai Medical Center, and pursued fellowship training in breast surgical oncology at Memorial Sloan Kettering Cancer Center. Board-certified in surgery, Dr. Port brings over two decades of expertise in diagnosing and treating all forms of breast cancer, specializing in advanced surgical techniques including nipple-sparing mastectomy, oncoplastic procedures, and minimally invasive approaches tailored to each patient’s unique condition and preferences.

She is highly regarded for her integrative, patient-focused approach and commitment to personalized cancer care. Her clinical and academic work centers on improving surgical outcomes, early detection, genetic risk evaluation, and patient decision-making. Dr. Port has published numerous peer-reviewed studies and authored The New Generation Breast Cancer Book, a widely respected resource for patients navigating diagnosis and treatment options. She is frequently sought after for expert commentary by national media outlets and is a leading voice at academic and patient-focused conferences. Her work exemplifies the union of evidence-based practice and empathetic care.

In addition to her clinical leadership, Dr. Port plays a pivotal role in educating future surgical oncologists and in shaping breast cancer care on a broader scale. She holds teaching and mentorship roles at the Icahn School of Medicine at Mount Sinai and is involved in institutional initiatives that advance equity, innovation, and multidisciplinary collaboration. Recognized with multiple honors for excellence in surgery, education, and patient advocacy, Dr. Port continues to elevate standards in breast cancer care through her expertise, innovation, and unwavering commitment to patients.